Report Detail
Global Efinaconazole Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3624758 |
- 26 July, 2019 |
- Global |
- 101 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis.
Scope of the Report:
The worldwide market for Efinaconazole is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Efinaconazole in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
VIRUJ PHARMA
Valeant
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Purity ≥ 98%
Purity ＜ 98%
Market Segment by Applications, can be divided into
Onychomycosis
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Efinaconazole product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Efinaconazole, with price, sales, revenue and global market share of Efinaconazole in 2017 and 2018.
Chapter 3, the Efinaconazole competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Efinaconazole breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Efinaconazole market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Efinaconazole sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Efinaconazole Introduction
- 1.2 Market Analysis by Type
- 1.2.1 Purity ≥ 98%
- 1.2.2 Purity ＜ 98%
- 1.3 Market Analysis by Applications
- 1.3.1 Onychomycosis
- 1.3.2 Other
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 VIRUJ PHARMA
- 2.1.1 Business Overview
- 2.1.2 Efinaconazole Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 VIRUJ PHARMA Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Valeant
- 2.2.1 Business Overview
- 2.2.2 Efinaconazole Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Valeant Efinaconazole Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Efinaconazole Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Efinaconazole Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Efinaconazole Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Efinaconazole Manufacturer Market Share in 2018
- 3.3.2 Top 6 Efinaconazole Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Efinaconazole Market Analysis by Regions
- 4.1 Global Efinaconazole Sales, Revenue and Market Share by Regions
- 4.1.1 Global Efinaconazole Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Efinaconazole Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Efinaconazole Sales and Growth Rate (2014-2019)
- 4.3 Europe Efinaconazole Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Efinaconazole Sales and Growth Rate (2014-2019)
- 4.5 South America Efinaconazole Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Efinaconazole Sales and Growth Rate (2014-2019)
5 North America Efinaconazole by Country
- 5.1 North America Efinaconazole Sales, Revenue and Market Share by Country
- 5.1.1 North America Efinaconazole Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Efinaconazole Revenue and Market Share by Country (2014-2019)
- 5.2 United States Efinaconazole Sales and Growth Rate (2014-2019)
- 5.3 Canada Efinaconazole Sales and Growth Rate (2014-2019)
- 5.4 Mexico Efinaconazole Sales and Growth Rate (2014-2019)
6 Europe Efinaconazole by Country
- 6.1 Europe Efinaconazole Sales, Revenue and Market Share by Country
- 6.1.1 Europe Efinaconazole Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Efinaconazole Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Efinaconazole Sales and Growth Rate (2014-2019)
- 6.3 UK Efinaconazole Sales and Growth Rate (2014-2019)
- 6.4 France Efinaconazole Sales and Growth Rate (2014-2019)
- 6.5 Russia Efinaconazole Sales and Growth Rate (2014-2019)
- 6.6 Italy Efinaconazole Sales and Growth Rate (2014-2019)
7 Asia-Pacific Efinaconazole by Country
- 7.1 Asia-Pacific Efinaconazole Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Efinaconazole Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Efinaconazole Revenue and Market Share by Country (2014-2019)
- 7.2 China Efinaconazole Sales and Growth Rate (2014-2019)
- 7.3 Japan Efinaconazole Sales and Growth Rate (2014-2019)
- 7.4 Korea Efinaconazole Sales and Growth Rate (2014-2019)
- 7.5 India Efinaconazole Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Efinaconazole Sales and Growth Rate (2014-2019)
8 South America Efinaconazole by Country
- 8.1 South America Efinaconazole Sales, Revenue and Market Share by Country
- 8.1.1 South America Efinaconazole Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Efinaconazole Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Efinaconazole Sales and Growth Rate (2014-2019)
- 8.3 Argentina Efinaconazole Sales and Growth Rate (2014-2019)
- 8.4 Colombia Efinaconazole Sales and Growth Rate (2014-2019)
9 Middle East and Africa Efinaconazole by Countries
- 9.1 Middle East and Africa Efinaconazole Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Efinaconazole Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Efinaconazole Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Efinaconazole Sales and Growth Rate (2014-2019)
- 9.3 Turkey Efinaconazole Sales and Growth Rate (2014-2019)
- 9.4 Egypt Efinaconazole Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Efinaconazole Sales and Growth Rate (2014-2019)
- 9.6 South Africa Efinaconazole Sales and Growth Rate (2014-2019)
10 Global Efinaconazole Market Segment by Type
- 10.1 Global Efinaconazole Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Efinaconazole Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Efinaconazole Revenue and Market Share by Type (2014-2019)
- 10.2 Purity ≥ 98% Sales Growth and Price
- 10.2.1 Global Purity ≥ 98% Sales Growth (2014-2019)
- 10.2.2 Global Purity ≥ 98% Price (2014-2019)
- 10.3 Purity ＜ 98% Sales Growth and Price
- 10.3.1 Global Purity ＜ 98% Sales Growth (2014-2019)
- 10.3.2 Global Purity ＜ 98% Price (2014-2019)
11 Global Efinaconazole Market Segment by Application
- 11.1 Global Efinaconazole Sales Market Share by Application (2014-2019)
- 11.2 Onychomycosis Sales Growth (2014-2019)
- 11.3 Other Sales Growth (2014-2019)
12 Efinaconazole Market Forecast (2019-2024)
- 12.1 Global Efinaconazole Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Efinaconazole Market Forecast by Regions (2019-2024)
- 12.2.1 North America Efinaconazole Market Forecast (2019-2024)
- 12.2.2 Europe Efinaconazole Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Efinaconazole Market Forecast (2019-2024)
- 12.2.4 South America Efinaconazole Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Efinaconazole Market Forecast (2019-2024)
- 12.3 Efinaconazole Market Forecast by Type (2019-2024)
- 12.3.1 Global Efinaconazole Sales Forecast by Type (2019-2024)
- 12.3.2 Global Efinaconazole Market Share Forecast by Type (2019-2024)
- 12.4 Efinaconazole Market Forecast by Application (2019-2024)
- 12.4.1 Global Efinaconazole Sales Forecast by Application (2019-2024)
- 12.4.2 Global Efinaconazole Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Efinaconazole. Industry analysis & Market Report on Efinaconazole is a syndicated market report, published as Global Efinaconazole Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Efinaconazole market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
